Vyvanse Drug Interactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Drug Interactions

Drugs Having Clinically Important Interactions with Amphetamines: See Table 5.

Click on icon to see table/diagram/image

Drugs Having No Clinically Important Interactions with VYVANSE: From a pharmacokinetic perspective, no dose adjustment of VYVANSE is necessary when VYVANSE is co-administered with guanfacine, venlafaxine, or omeprazole. In addition, no dose adjustment of guanfacine or venlafaxine is needed when VYVANSE is co-administered [see Pharmacology: Pharmacokinetics under Actions].
From a pharmacokinetic perspective, no dose adjustment for drugs that are substrates of CYP1A2 (e.g., theophylline, duloxetine, melatonin), CYP2D6 (e.g., atomoxetine, desipramine, venlafaxine), CYP2C19 (e.g., omeprazole, lansoprazole, clobazam), and CYP3A4 (e.g., midazolam, pimozide, simvastatin) is necessary when VYVANSE is co-administered [see Pharmacology: Pharmacokinetics under Actions].

lisdexamfetamine

Manufacturer:

Takeda

Distributor:

Zuellig